Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)
Stopped COVID environment, lack of site confidence to enroll subjects, sites not suited to study procedures, decline of potential inpatient subjects at site
Conditions
- 2019 Novel Coronavirus Disease
- 2019 Novel Coronavirus Infection
- 2019-nCoV Disease
- 2019-nCoV Infection
- COVID-19 Pandemic
- COVID-19 Virus Disease
- COVID-19 Virus Infection
- Covid19
- Coronavirus Disease 2019
- SARS-CoV-2 Infection
- SARS-CoV-2 Acute Respiratory Disease
- COVID-19
Interventions
- DRUG: Famotidine
- DRUG: Celecoxib
- DRUG: Placebo
Sponsor
Leidos Life Sciences
Collaborators